{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:54:52Z","timestamp":1761519292129},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1245\/s10434-019-08191-0","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T17:05:01Z","timestamp":1579799101000},"page":"2248-2254","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Radiographic Surveillance of Patients with Non-BRCA1\/2 Pathogenic Variants"],"prefix":"10.1245","volume":"27","author":[{"given":"Laura","family":"Hudson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Gower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy","family":"Lenarcic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally J.","family":"Trufan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Richard L.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,23]]},"reference":[{"issue":"7418","key":"8191_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","unstructured":"Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70. https:\/\/doi.org\/10.1038\/nature11412.","journal-title":"Nature"},{"issue":"7","key":"8191_CR2","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/annonc\/mdv022","volume":"26","author":"S Shiovitz","year":"2015","unstructured":"Shiovitz S, Korde LA. Genetics of breast cancer: a topic in evolution. Ann Oncol. 2015;26(7):1291-1299. https:\/\/doi.org\/10.1093\/annonc\/mdv022. Epub 2015 Jan 20.","journal-title":"Ann Oncol"},{"issue":"5","key":"8191_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S1470-2045(11)70076-6","volume":"12","author":"B Zhang","year":"2011","unstructured":"Zhang B, Beeghly-Fadiel A, Long J, Zheng W. Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol. 2011;12(5):477\u2013488. https:\/\/doi.org\/10.1016\/s1470-2045(11)70076-6.","journal-title":"Lancet Oncol"},{"key":"8191_CR4","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1245\/s10434-015-4754-2","volume":"22","author":"NS Kapoor","year":"2015","unstructured":"Kapoor NS, Curcio LD, Blakemore CA, et al. Multigene panel testing detects equal rates of pathogenic BRCA1\/2 pathogenic variants and has a higher diagnostic yield compared to limited BRCA1\/2 analysis alone in patients at risk for hereditary breast cancer. Ann Surg Oncol. 2015;22:3282\u20133288. https:\/\/doi.org\/10.1245\/s10434-015-4754-2.","journal-title":"Ann Surg Oncol"},{"key":"8191_CR5","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Genetic\/familial high-risk assessment: breast and ovarian. Version 2.2019. www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf."},{"key":"8191_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrclinonc.2016.90","volume":"13","author":"N Tung","year":"2016","unstructured":"Tung N, Domchek SM, Stadler Z, et al. Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nat Rev Clin Oncol. 2016;13:581-588. https:\/\/doi.org\/10.1038\/nrclinonc.2016.90.","journal-title":"Nat Rev Clin Oncol."},{"key":"8191_CR7","unstructured":"Schneider K, Zelley K, Nichols KE, et al. Li-Fraumeni Syndrome. 1999 [Updated 2013 Apr 11]. In: Pagon RA, Adam MP, Bird TD, et al., editors. GeneReviews\u2122 [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132013. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1311\/ (Accessed on September 5, 2013)."},{"key":"8191_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/34432","volume":"391","author":"A Hemminki","year":"1998","unstructured":"Hemminki A, Markie D, Tomlinson I, et al. A serine\/threonine kinase gene defective in Peutz\u2013eghers syndrome. Nature. 1998;391:184\u2013187.","journal-title":"Nature"},{"key":"8191_CR9","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/gut.2009.198499","volume":"59","author":"AD Beggs","year":"2010","unstructured":"Beggs AD, Latchford AR, Vasen HF, et al. Peutz\u2013eghers syndrome: a systematic review and recommendations for management. Gut. 2010;59:975\u2013986. https:\/\/doi.org\/10.1136\/gut.2009.198499.","journal-title":"Gut."},{"key":"8191_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","volume":"1","author":"S Hansford","year":"2015","unstructured":"Hansford S, Kaurah P, Li-Chang H, et al. Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. JAMA Oncol. 2015;1:23\u201332. https:\/\/doi.org\/10.1001\/jamaoncol.2014.168.","journal-title":"JAMA Oncol."},{"key":"8191_CR11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","volume":"18","author":"MH Tan","year":"2012","unstructured":"Tan MH, Mester JL, Ngeow J, et al. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res. 2012;18:400\u2013407. https:\/\/doi.org\/10.1158\/1078-0432.ccr-11-2283.","journal-title":"Clin Cancer Res."},{"key":"8191_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/94.3.205","volume":"94","author":"G Chenevix-Trench","year":"2002","unstructured":"Chenevix-Trench G, Spurdle AB, Gatei M, et al. Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst. 2002;94:205\u2013215.","journal-title":"J Natl Cancer Inst."},{"key":"8191_CR13","doi-asserted-by":"publisher","first-page":"12081216","DOI":"10.1200\/JCO.2015.63.3594","volume":"34","author":"C N\u00e4slund-Koch","year":"2016","unstructured":"N\u00e4slund-Koch C, Nordestgaard BG, Bojesen SE. Increased risk for other cancers in addition to breast cancer for CHEK2*1100delC heterozygotes estimated from the copenhagen general population study. J Clin Oncol. 2016;34:12081216. https:\/\/doi.org\/10.1200\/jco.2015.63.3594.","journal-title":"J Clin Oncol."},{"issue":"6","key":"8191_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.18.01631","volume":"37","author":"PD Beitsch","year":"2019","unstructured":"Beitsch PD, Whitworth PW, Hughes K, et al. Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle? J Clin Oncol. 2019;37(6):453\u2013460. https:\/\/doi.org\/10.1200\/jco.18.01631.","journal-title":"J Clin Oncol."},{"issue":"10","key":"8191_CR15","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.30498","volume":"123","author":"SS Buys","year":"2017","unstructured":"Buys SS, Sandbach JF, Gammon A, et al. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer. 2017;123(10):1721\u20131730. https:\/\/doi.org\/10.1002\/cncr.30498.","journal-title":"Cancer."},{"issue":"7","key":"8191_CR16","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/jnci\/djx265","volume":"110","author":"R Manchanda","year":"2018","unstructured":"Manchanda R, Patel S, Gordeev VS, et al. Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women. J Natl Cancer Inst. 2018;110(7):714\u2013725. https:\/\/doi.org\/10.1093\/jnci\/djx265.","journal-title":"J Natl Cancer Inst."},{"key":"8191_CR17","unstructured":"American Society of Breast Surgeons Consensus Guideline on Genetic Testing for Hereditary Breast Cancer. Published February 2019."},{"key":"8191_CR18","doi-asserted-by":"crossref","unstructured":"Lord SJ, Lei W, Craft P, Cawson JN, Morris I, Walleser S, Griffiths A, Parker S, Houssami N. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer. 2007;43(13):1905\u20131917. Epub 2007 Aug 2. Review. PubMed PMID: 17681781.","DOI":"10.1016\/j.ejca.2007.06.007"},{"issue":"10","key":"8191_CR19","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/gim.2017.255","volume":"20","author":"L Petelin","year":"2018","unstructured":"Petelin L, Trainer AH, Mitchell G, Liew D, James PA. Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1\/2 mutation carriers: a systematic review. Genet Med. 2018;20(10):1145\u20131156. https:\/\/doi.org\/10.1038\/gim.2017.255. Epub 2018 Jan 11. PubMed PMID: 29323669.","journal-title":"Genet Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-08191-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-08191-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-08191-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:45:49Z","timestamp":1611276349000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-08191-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,23]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["8191"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-08191-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,23]]},"assertion":[{"value":"5 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}